Health Care & Life Sciences » Biotechnology | AEterna Zentaris Inc.

AEterna Zentaris Inc. | Ownership

Companies that own AEterna Zentaris Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Morgan Stanley & Co. LLC
215,666
2.17%
108,400
0%
06/30/2018
JPMorgan Securities LLC (Investment Management)
79,900
0.8%
-1,000
0%
06/30/2018
Acadian Asset Management LLC
35,409
0.36%
35,409
0%
06/30/2018
Renaissance Technologies LLC
33,078
0.33%
-1,300
0%
06/30/2018
Morgan Stanley Canada Ltd.
30,600
0.31%
0
0%
06/30/2018
Susquehanna Financial Group LLLP
25,291
0.25%
10,402
0%
06/30/2018
DWS Investment GmbH
21,711
0.22%
-1,600
0%
06/30/2018
G1 Execution Services LLC
18,353
0.19%
-40,617
0%
06/30/2018
Millennium Management LLC
10,553
0.11%
10,553
0%
06/30/2018
Morgan Stanley Smith Barney LLC (Private Banking)
2,801
0.03%
200
0%
06/30/2018

About AEterna Zentaris

View Profile
Address
315 Sigma Drive
Charleston South Carolina 29486
United States
Employees -
Website http://www.aezsinc.com
Updated 07/08/2019
Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company that is engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. It operates through biopharmaceutical segment. AEterna Zentaris was founded on September 12, 1990 and is headquartered in Charleston, SC.